Literature DB >> 21039589

Management of hyperglycemia in hospitalized patients.

Dawn Smiley1, Guillermo E Umpierrez.   

Abstract

Hyperglycemia is a common occurrence in hospitalized patients, and several studies have shown a strong association between hyperglycemia and the risk of complications, prolonged hospitalization, and death for patients with and without diabetes. Past studies have shown that glucose management in the intensive care setting improves clinical outcomes by reducing the risk of multiorgan failure, systemic infection, and mortality, and that the importance of hyperglycemia also applies to noncritically ill patients. Based on several past observational and interventional studies, aggressive control of blood glucose had been recommended for most adult patients with critical illness. Recent randomized controlled trials, however, have shown that aggressive glycemic control compared to conventional control with higher blood glucose targets is associated with an increased risk of hypoglycemia and may not result in the improvement in clinical outcomes. This review aims to give an overview of the evidence for tight glycemic control (blood glucose targets <140 mg/dL), the evidence against tight glycemic control, and the updated recommendations for the inpatient management of diabetes in the critical care setting and in the general wards.
© 2010 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2010        PMID: 21039589      PMCID: PMC3733469          DOI: 10.1111/j.1749-6632.2010.05805.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  80 in total

1.  Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study: response to Delea et al.

Authors:  Andrew J Karter; Ameena T Ahmed; Jennifer Liu; Howard H Moffet; Melissa M Parker; Assiamira Ferrara; Joe V Selby
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

2.  A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

Authors:  C L Meinert; G L Knatterud; T E Prout; C R Klimt
Journal:  Diabetes       Date:  1970       Impact factor: 9.461

3.  Coronary heart disease mortality risk: plasma insulin level is a more sensitive marker than hypertension or abnormal glucose tolerance in overweight males. The Paris Prospective Study.

Authors:  A Fontbonne; G Tchobroutsky; E Eschwege; J L Richards; J R Claude; G E Rosselin
Journal:  Int J Obes       Date:  1988

Review 4.  Role of insulin in management of surgical patients with diabetes mellitus.

Authors:  I B Hirsch; J B McGill
Journal:  Diabetes Care       Date:  1990-09       Impact factor: 19.112

5.  Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.

Authors:  E Deutsch; M Berger; W G Kussmaul; J W Hirshfeld; H C Herrmann; W K Laskey
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

6.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

7.  Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.

Authors:  Frankie B Stentz; Guillermo E Umpierrez; Ruben Cuervo; Abbas E Kitabchi
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

8.  Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect.

Authors:  Ahmad Aljada; Priya Mohanty; Husam Ghanim; Toufic Abdo; Devjit Tripathy; Ajay Chaudhuri; Paresh Dandona
Journal:  Am J Clin Nutr       Date:  2004-04       Impact factor: 7.045

9.  Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

Authors:  F Tomai; F Crea; A Gaspardone; F Versaci; R De Paulis; A Penta de Peppo; L Chiariello; P A Gioffrè
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

10.  Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI.

Authors:  K A Malmberg; S Efendic; L E Rydén
Journal:  Diabetes Care       Date:  1994-09       Impact factor: 19.112

View more
  10 in total

1.  Update on inpatient diabetes management: call for action.

Authors:  Guillermo E Umpierrez; Kathleen Dungan
Journal:  Diabetes Technol Ther       Date:  2015-04       Impact factor: 6.118

Review 2.  Perioperative Hyperglycemia Management: An Update.

Authors:  Elizabeth W Duggan; Karen Carlson; Guillermo E Umpierrez
Journal:  Anesthesiology       Date:  2017-03       Impact factor: 7.892

3.  Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia.

Authors:  Ajay Chaudhuri; Guillermo E Umpierrez
Journal:  J Diabetes Complications       Date:  2012-05-31       Impact factor: 2.852

Review 4.  Closed-loop insulin delivery: from bench to clinical practice.

Authors:  Roman Hovorka
Journal:  Nat Rev Endocrinol       Date:  2011-02-22       Impact factor: 43.330

5.  Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes.

Authors:  Farnoosh Farrokhi; Olena Klindukhova; Prakash Chandra; Limin Peng; Dawn Smiley; Christopher Newton; Francisco Pasquel; Maria E Fereira; Guillermo Umpierrez
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

6.  Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes.

Authors:  Dawn Smiley; Guillermo E Umpierrez; Kathie Hermayer; Christopher Newton; Sol Jacobs; Darin E Olson; Amna Khan; Monica Rizzo; Limin Peng; David Reyes; Saumeth Cardona; Vivian Fonseca
Journal:  J Diabetes Complications       Date:  2013-08-01       Impact factor: 2.852

7.  Hyperglycemia in poor controlled diabetes from crude tamarind herbal pill: a case study.

Authors:  Viroj Wiwanitkit
Journal:  Asian Pac J Trop Biomed       Date:  2011-01

8.  Creating a perioperative glycemic control program.

Authors:  Sara M Alexanian; Marie E McDonnell; Shamsuddin Akhtar
Journal:  Anesthesiol Res Pract       Date:  2011-09-06

9.  The Effect of Glucose Levels Prior to Hematopoietic Cell Transplantation on Post-Transplant Complications and Health Resource Utilization.

Authors:  Amir Steinberg; Janet H Van Cleave; Anish B Parikh; Erin Moshier; Meng Ru; Molly Lawson; Douglas Marks; Antoinette Montelibano; Amanda Philpott; Kourtney Garner; Marilyn J Hammer
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2019-07-01

10.  Inpatient hyperglycemia: Clinical management needs in teaching hospital.

Authors:  H E Tamez-Pérez; D L Quintanilla-Flores; S L Proskauer-Peña; J G González-González; M I Hernández-Coria; L A Garza-Garza; A L Tamez-Peña
Journal:  J Clin Transl Endocrinol       Date:  2014-10-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.